# Clickalign

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clickalign

- Industry: Healthcare Specialists
- Headquarters: Beijing, China
- Website: www.clickalign.com
- Latest round: Series B (Aug 24, 2021)
- Investors on record: 5

## About

Based in Beijing, China and established in 2015, Clickalign is a solution provider of invisible orthodontic and it focuses on developing invisible removable orthodontic appliance. Up to now, the sales team of company has exceeded 2000 people, and it has more than 80000 online doctor serve for more than 10,000 users per month. It has established branches in more than 30 cities. In August 2021, the company raised an undisclosed amount of series B funding led by Shiyu Capital and followed by CreditEase Wealth Management (Beijing) and Suzhou Fund. In 2008, the company launched academic exchange activities, it has entered 29 provinces, covering 450 regions. More than 2000 professional academic courses were held and 60000 doctors were trained. It has a partnership with ARRAIL, BOE, Peakvest and Ovctek.

The company provides users with college, online mall and click OS system. The company's college is based on orthodontics, it covers the contents of oral restoration, implant, intraoral and extraoral, and involves the relevant training of doctor's assistants and nurses. In addition, the college also offers courses in non oral areas such as management of hospital, psychology and law.

## Funding rounds

- Series B, Aug 24, 2021 — CreditEase Wealth Management, Shiyu Capital, Suzhou Equity Investment Fund Management
- Series A, Apr 8, 2019 — CITIC Capital Holdings, Alwin Capital

## Investors

- CITIC Capital Holdings (https://capitalatlas.ai/funds/citic-capital-holdings) — Series A
- Alwin Capital — Series A
- CreditEase Wealth Management (https://capitalatlas.ai/funds/creditease-wealth-management) — Series B
- Shiyu Capital (https://capitalatlas.ai/funds/shiyu-capital) — Series B
- Suzhou Equity Investment Fund Management (https://capitalatlas.ai/funds/suzhou-equity-investment-fund-management) — Series B
